FindMyKOL

Cassandra Calabrese, DO

Basic profile

Cleveland Clinic

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionCleveland, OH · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLFindMyKOL type: NationalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Cassandra Calabrese is a Rheumatology/Immunology physician affiliated with Cleveland Clinic. OpenAlex indexes 112 publications with 3,712 citations (h-index 29).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
112publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,712citations

Citations across these publications.

29h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • GENZYME CORPORATION
    Program year20255 payments
    $9,128
  • Invivyd Inc
    Program year20253 payments
    $3,738
  • Amgen Inc.
    Program year20253 payments
    $321
All 18 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    41.4%
    Folate Analog Metabolic Inhibitor13.6%
    Methotrexate100%
    Part D≥23 patients
    TNF inhibitor9.2%
    Humira(Cf) Pen47%Enbrel Sureclick37%Humira Pen16%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    30.7%
    Corticosteroid27.4%
    Prednisone100%
    Part D≥58 patients
    Proton pump inhibitor1.9%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 1 more class in this area

  • Antiparasitic

    18.1%
    Antimalarial18.1%
    Hydroxychloroquine Sulfate100%
    Part D≥34 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”